FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Hackers tied to Iran breach FBI director’s personal email and post private images

Secret Service agent assigned to Jill Biden injured in ‘negligent discharge’ at Philadelphia airport

AOC says politicians, especially Democrats, should promise not to accept ‘AI money’

Sheridan Gorman’s university newspaper touts ICE tracker after freshman allegedly murdered by illegal alien

Movie Review: Hopeful Comedy ‘Home Delivery’ Delivers Heart, Laughs, and Free Admission for Expectant Mothers

Savannah Guthrie to return to Today show after absence

‘Maybe It Wasn’t a Bug…’ Internet Weighs In on Man Who Discovered He Could Access 7,000 Robotic Vacuums

Battleground Dem candidate linked public displays of faith to political violence in 2023 speech

Senate passes overnight bill to fund most of Homeland Security as fight nears end and more top headlines

Fetterman tells far-left prosecutor to ‘lighten up’ after threatening to arrest ICE agents over raids

FTC commissioner likens American Bar Association to ‘communist party’ over far-left advocacy

NHL’s Nashville Predators Unveil New LGBT Logo, and It Doesn’t Land the Way They Hoped

Just In: Trump’s Legacy Will Now Appear on All New US Currency

Sorely needed US housing supply expansion may run through 3D printed homes

Israel has recognized Somaliland. Will the US follow?

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”